Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    ORAL 03 - New Kinase Targets

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:F. Blackhall
    • Coordinates: 9/07/2015, 10:45 - 12:15, Mile High Ballroom 4a-4f
    • +

      ORAL03.01 - Anlotinib as 3rd-Line Treatment for Refractory Advanced NSCLC: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

      10:45 - 10:56  |  Author(s): B. Han

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL03.02 - Is EGFR Exon20 Mutation a Prognostic/Predictive Biomarker in Our Lung Cancer Patients?

      10:56 - 11:07  |  Author(s): D.S. Joy Philip

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL03.03 - EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Sensitivity to Afatinib or Neratinib but Not to Other EGFR-TKIs

      11:07 - 11:18  |  Author(s): Y. Kobayashi

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL03.04 - Discussant for ORAL03.01, ORAL03.02, ORAL03.03

      11:18 - 11:28  |  Author(s): H. West

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL03.05 - Clinical Outcomes with Pemetrexed-Based Systemic Therapy in RET-Rearranged Lung Cancers

      11:28 - 11:39  |  Author(s): A. Drilon

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL03.06 - Activity of Crizotinib in MET Amplified NSCLC: Preliminary Results of the AcSé Trial

      11:39 - 11:50  |  Author(s): D. Moro-Sibilot

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL03.07 - Response to MET Inhibitors in Stage IV Lung Adenocarcinoma Patients with Mutations That Cause MET Exon 14 Skipping

      11:50 - 12:01  |  Author(s): P. Paik

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL03.08 - Discussant for ORAL03.05, ORAL03.06, ORAL03.07

      12:01 - 12:11  |  Author(s): R. Salgia

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MS 07 - SCLC Biology & Models

    • Type: Mini Symposium
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 6
    • Moderators:D. Carney
    • Coordinates: 9/07/2015, 14:15 - 15:45, Mile High Ballroom 4a-4f
  • +

    ORAL 25 - Biology and Other Issues in SCLC

    • Type: Oral Session
    • Track: Small Cell Lung Cancer
    • Presentations: 8
    • Moderators:J. Sage
    • Coordinates: 9/08/2015, 10:45 - 12:15, 605+607
    • +

      ORAL25.02 - Vasculogenic Mimicry in Small Cell Lung Cancer

      10:56 - 11:07  |  Author(s): K.L. Simpson

      • Abstract

      Loading...

  • +

    MINI 16 - EGFR Mutant Lung Cancer 2

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:G.J. Riely
    • Coordinates: 9/08/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
    • +

      MINI16.09 - Design, Execution, and Preliminary Biomarker Results from Paired Tumor Biopsy Cohorts of the AZD9291 AURA Trial

      17:30 - 17:35  |  Author(s): K. Thress

      • Abstract

      Loading...

  • +

    MINI 22 - New Technology

    • Type: Mini Oral
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 13
    • Moderators:L. Byers
    • Coordinates: 9/08/2015, 16:45 - 18:15, 205+207
    • +

      MINI22.12 - Molecular Characterisation of SCLC Using Both Circulating Tumour DNA and Circulating Tumour Cells Isolated from the Same Whole Blood Sample

      17:50 - 17:55  |  Author(s): D.G. Rothwell

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 91
    • Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P3.01-079 - Addition of Hsp27 Inhibitor Apatorsen to First-Line Gemcitabine/Carboplatin in Advanced Squamous Cell Lung Cancer: Design of the Cedar™ Trial

      09:30 - 09:30  |  Author(s): P. Schmid

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.04 - Poster Session/ Biology, Pathology, and Molecular Testing

    • Type: Poster
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 134
    • Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P3.04-009 - Evaluation of RT-PCR Methodology for ALK Assessment in Patients with NSCLC in Europe: Results from the ETOP Lungscape Project

      09:30 - 09:30  |  Author(s): I. Letovanec

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 37 - Novel Targets

    • Type: Oral Session
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 8
    • Moderators:S.S. Ramalingam
    • Coordinates: 9/09/2015, 16:45 - 18:15, Mile High Ballroom 4a-4f
    • +

      ORAL37.05 - Prevalence and Clinical Association of MET Gene Amplification in Patients with NSCLC: Results from the ETOP Lungscape Project

      17:28 - 17:39  |  Author(s): L. Bubendorf

      • Abstract

      Loading...

  • +

    MINI 31 - ALK

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:S. Malik
    • Coordinates: 9/09/2015, 18:30 - 20:00, Mile High Ballroom 1a-1f